Home/Evolus/Lauren Silvernail
LS

Lauren Silvernail

Chief Financial Officer

Evolus

Therapeutic Areas

Evolus Pipeline

DrugIndicationPhase
Jeuveau (prabotulinumtoxinA-xvfs)Moderate to Severe Glabellar LinesApproved
Evolysse SmoothWrinkles in Dynamic Facial Areas (e.g., NLFs)Approved
Evolysse FormWrinkles in Dynamic Facial Areas (e.g., NLFs)Approved